Statistics for EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients

Total visits

views
EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients 86

Total visits per month

views
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0

File Visits

views
HillGallant_2020_EOS789.pdf 197
java.util.UUID:d70bf34a-dad9-4bf3-8a78-70421026d985 82
java.util.UUID:389245e4-d77e-4416-8cf8-cda03c7aa3ae 9
java.util.UUID:6f23f40a-ec15-4db4-8a54-084f786bef01 4

Top country views

views
United States 68
Canada 3
Germany 1
United Kingdom 1
Malaysia 1
Russia 1
Sweden 1

Top city views

views
Wilmington 40
Fairfield 8
Houston 5
Toronto 3
Cambridge 2
Washington 2
Baltimore 1
Belvedere Tiburon 1
Bloomington 1
Chicago 1
Jacksonville 1
Kiez 1
London 1
Osaka 1
Saint Petersburg 1
Seattle 1
Seremban 1
Stockholm 1